# Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms

> **NCT05990621** · PHASE1 · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 60 (estimated)

## Conditions studied

- CD70-positive Advanced Urologic Neoplasms

## Interventions

- **BIOLOGICAL:** Anti-CD70 CAR-T cells

## Key facts

- **NCT ID:** NCT05990621
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-31
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05990621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05990621, "Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05990621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*